1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
EFFECTS OF TERBUTALINE ON MYOMETRIAL ACTIVITY, UTERINE BLOOD FLOW, AND LOWER ABDOMINAL PAIN IN WOMEN WITH PRIMARY DYSMENORRHOEA
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1976.tb00911.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 83, Issue 9, pages 673–678, September 1976
Additional Information
How to Cite
ÅKerlund, M., Andersson, K.-E. and Ingemarsson, I. (1976), EFFECTS OF TERBUTALINE ON MYOMETRIAL ACTIVITY, UTERINE BLOOD FLOW, AND LOWER ABDOMINAL PAIN IN WOMEN WITH PRIMARY DYSMENORRHOEA. BJOG: An International Journal of Obstetrics & Gynaecology, 83: 673–678. doi: 10.1111/j.1471-0528.1976.tb00911.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Abstract
- References
- Cited By
Summary
The effects of the selective β2-receptor stimulator terbutaline (0·25 to 0·5 mg given intravenously) on myometrial activity, local uterine blood flow, and lower abdominal pain were examined during the first day of menstruation in 11 women with severe primary dysmenorrhoea. All had maximum intrauterine pressures between 200 and 350 mm Hg. During uterine contractions of high amplitude or long duration, the local endometrial blood flow decreased markedly, and the patients experienced the most intense pain. Terbutaline inhibited the myometrial activity, increased the blood flow, and relieved the pain.